E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/16/2013 in the Prospect News PIPE Daily and Prospect News Private Placement Daily.

MannKind to wrap $40 million tranche of $160 million convertibles sale

9.75% notes convert to stock based on volume-weighted average price

By Devika Patel

Knoxville, Tenn., Aug. 16 - MannKind Corp. said the conditions for the second $40 million tranche of a $160 million private placement of convertible senior secured notes with Deerfield Management Company LP have been satisfied. The sale is being conducted in four tranches of $40 million each and priced on July 1.

The 9.75% notes are due in 2019, and a portion of the principal will convert to common shares based on the volume-weighted average price of the stock during the 20 trading days immediately preceding the conversion date.

Settlement of the second tranche is expected on Sept. 6.

Valencia, Calif.-based MannKind is a biopharmaceutical company specializing in the discovery, development and commercialization of therapeutic products for diseases.

Issuer:MannKind Corp.
Issue:Convertible senior secured notes
Amount:$160 million
Maturity:2019
Coupon:9.75%
Warrants:No
Investor:Deerfield Management Company LP
Pricing date:July 1
Settlement date:Sept. 6 (for $40 million)
Stock symbol:OTCBB: MNKD
Stock price:$6.51 at close June 28
Market capitalization:$1.74 billion

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.